Layoffs
Dart will close its doors on Feb. 9 due to poor progress on its therapeutic goals and little return on hundreds of millions of dollars in R&D.
Layoffs are expected to begin in February, according to reports.
Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next two years.
Avanir Pharmaceuticals will lay off 11 percent of its workforce by the end of January 2018 as part of a company restructuring.
The first round of Indiana employees are expected to be let go January 31 and continue through the end of September.
Novartis told Kent Online that the reason the company is looking at closing the facility is the rapid advancements in point of care diagnostic devices.
Nine months after a new leadership team was put in place, Depomed is looking to relocate its Bay Area HQ after inking a deal with Collegium Pharma.
Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility.
Otonomy said dropping the program and terminating the employees will provide a cash savings of more than $20M in 2018.
Share prices for Protalix are up more than 3 percent this morning after the company reported positive results from its Phase I/II open label extension trial of pegunigalsidase alfa, PRX-102, for the treatment of Fabry disease.
PRESS RELEASES
